Sector Healthcare Value X USD Acc |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 0.9 | 19.7 | 6.0 | -1.6 | 1.5 | |
+/-Cat | -10.3 | 3.0 | 15.8 | -0.8 | -1.9 | |
+/-Idx | - | -6.4 | 5.9 | -1.4 | -4.8 | |
Category: Sector Equity Healthcare | ||||||
Benchmarks: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 16/05/2024 | USD 185.81 | |
Day Change | -0.24% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00BYPZZL39 | |
Fund Size (Mil) 16/05/2024 | USD 429.73 | |
Share Class Size (Mil) 16/05/2024 | USD 27.51 | |
Max Initial Charge | - | |
Ongoing Charge 18/04/2024 | 0.75% |
Investment Objective: Sector Healthcare Value X USD Acc |
The investment process behind Sector Healthcare Value Fund is based on a fundamentally driven model for bottom up stock valuation within the global Healthcare and Biotech sector. The portfolio will contain 20-40 long positions. Value creation and valuation: Valuation is the single most important factor in the investment team's model. Several valuation models are used, and they based on an in-house view on normalised earnings, future growth/returns and the duration of the growth. Momentum and sentiment: The investment team also considers more short term factors which can modify their long-term fundamental view. The investment team may also take risk on these factors unless the company is significantly overvalued. Portfolio construction: the investment manager considers the degree of mis-pricing given by the scorecard model relative to the total risk of the individual security expressed through the security's history and options' implied volatility. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Trond Horneland 16/11/2010 | ||
Inception Date 20/03/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Sector Healthcare Value X USD Acc | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
GSK PLC | Healthcare | 7.40 |
Roche Holding AG | Healthcare | 6.25 |
Medtronic PLC | Healthcare | 5.48 |
Pfizer Inc | Healthcare | 5.02 |
Sanofi SA | Healthcare | 4.42 |
Increase Decrease New since last portfolio | ||
Sector Healthcare Value X USD Acc |